JPRN-UMIN000050222
Recruiting
未知
Clinical efficacy and predictors of effectiveness to anti-TSLP antibody (tezepelumab) in patients with asthma - Clinical efficacy and predictors of effectiveness to anti-TSLP antibody (tezepelumab) in patients with asthma
agoya City University0 sites36 target enrollmentFebruary 3, 2023
ConditionsAsthma, Cough predominant asthma
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Asthma, Cough predominant asthma
- Sponsor
- agoya City University
- Enrollment
- 36
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patients with other obvious respiratory complications such as lung cancer, interstitial lung disease, etc. 2\) Pregnant or lactating patients. 3\) Patients who are judged to be inappropriate as subjects by the principal investigator.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
Evaluation of improvement of fatigue in the legs and feetChronic venous insufficiencyM54.5RBR-2skhs4Medcin Instituto da Pele
Completed
Not Applicable
Evaluation of improvement of fatigue in the legs and feetChronic Venous InsufficiencyI87.2RBR-893zqwMedcin Instituto da Pele
Not yet recruiting
Phase 1
Clinical Efficacy Evaluation and Mechanism Study of Anti-Hepatic Fibrosis Effectively Treated Prescription by Supplementing Deficiency and Clearing CollateralsITMCTR2100005161Chengdu University of Traditional Chinese Medicine
Recruiting
Not Applicable
The relationship between clinical efficacy and efficacy as measured by two versions of the Continuous Performance Test of OROS-Methylphenidate in adults with ADHD: a double blind placebo controlled medication trial.ADHD10037176NL-OMON31400Parnassia (Den Haag)44
Completed
Not Applicable
Clinical Research on the efficacy evaluation and the biomarker of nivolumab to an advance malignant melanomamalignant melanomaJPRN-UMIN000016608Public Health Research Foundation128